Section 2: Permanent access to the national health data system for certain public services

Articles in this section · 7

Article R1461-14

French Public Health CodeIn force

Updated 4 Nov 2023

The processing mentioned in Article R. 1461-11 concerns categories of data from the national health data system which may not exceed the following limits:

1° All individual data from the national health data system with cross-referencing of potential identifiers, samples with cross-referencing of potential identifiers, semi-aggregated data, individualised for healthcare professionals or establishments and aggregated for beneficiaries, and aggregated data presenting a residual risk of re-identification, for the Directorate for Research, Studies, Evaluation and Statistics, the Directorate for Social Security, the Directorate General for Health and the Directorate General for Healthcare, the national funds for compulsory health insurance schemes, the National Solidarity Fund for Autonomy, the High Authority for Health, the National Public Health Agency, the National Agency for the Safety of Medicines and Healthcare Products, the Biomedicine Agency, the National Cancer Institute, the French Blood Establishment and the Technical Agency for Information on Hospitalisation, the Plateforme des données de santé, the Institut de recherche et documentation en économie de la santé, the Institut national d'études démographiques, the Secrétariat général des ministères sociaux, the Observatoire français des drogues et des toxicomanies, the research teams of the Institut national de la santé et de la recherche médicale, the research teams of university hospitals and cancer centres, research and training teams at the École des Hautes Études en Santé Publique, the Institut National de la Statistique et des Études Économiques, the Agence Centrale des Organismes de Sécurité Sociale, research teams at the Centre National de la Recherche Scientifique as part of projects relating to public health, research teams at the Institut National de Recherche en Informatique et en Automatique as part of projects relating to public health and the Cour des Comptes;

2° All individual data from the national health data system with cross-referencing of potential identifiers within their territorial jurisdiction, where applicable, nationally, with regard to the place of residence of the beneficiary or the place where the procedure is carried out by the healthcare professional, all data from the information systems mentioned in Article L. 6113-7 with cross-referencing of potential identifiers, generalist samples with cross-referencing of potential identifiers, semi-aggregated data, individualised data for healthcare professionals or establishments and aggregated data for beneficiaries, as well as aggregated data presenting a residual risk of re-identification, for the regional health agencies, local and regional compulsory health insurance bodies and regional health observatories ;

3° All individual data from the national health data system with cross-referencing of potential identifiers on the scope of persons affiliated to the National Military Social Security Fund, generalist samples with cross-referencing of potential identifiers, semi-aggregated data, individualised for healthcare professionals or establishments and aggregated for beneficiaries, and aggregated data presenting a residual risk of re-identification, for the armed forces health service;

3° bis All individual data from the national health data system without cross-referencing potential identifiers, generalist samples with a maximum of two potential identifiers, semi-aggregated individualised data for healthcare professionals or establishments and aggregated data for beneficiaries, and aggregated data presenting a residual risk of re-identification, for the Budget Directorate and the Treasury Directorate-General;

4° (Repealed) ;

5° Samples with a maximum of two potential identifiers, semi-aggregated data, individualised for healthcare professionals or establishments and aggregated for beneficiaries, and aggregated data presenting a residual risk of re-identification, for the Autorité de sûreté nucléaire, the Institut de radioprotection et de sûreté nucléaire, the Haut Conseil pour l'avenir de l'assurance maladie, the Fonds de financement de la couverture maladie universelle, and the Agence nationale d'appui à la performance des établissements de santé et médico-sociaux ;

6° Semi-aggregated data, individualised for healthcare professionals or establishments and aggregated for beneficiaries, and aggregated data presenting a residual risk of re-identification, for regional unions of healthcare professionals.

Mariela Petrova

Need help applying this article to your situation?

A registered French Lawyer explains what applies to your business — in English, fixed fee.

within 48h

Fixed Fee

Talk to a lawyer
Common Questions

Working with a corporate lawyer in France — Q&A

Any time a strategic decision changes how the company is owned, governed or contractually bound — incorporation, fundraising, M&A, restructuring, shareholder agreements, or major commercial contracts. Earlier engagement always costs less than later remediation.

A notary (notaire) is a public officer who authenticates specific deeds (mainly real-estate transfers and certain family-law acts). A corporate lawyer (avocat) advises on strategy, negotiates and drafts company documents, and represents you in disputes. The two roles complement rather than overlap.

Yes — most of our clients are foreign suppliers, investors or holding entities. We bridge the gap between French law and your home jurisdiction's expectations and deliver everything bilingually.

The SAS (Société par Actions Simplifiée) is the default choice for most international structures: flexible governance, single shareholder allowed, no minimum capital, and works cleanly with foreign holding entities. We assess SARL, SA, SCI on the merits when the situation calls for it.

Yes — communications with a French avocat are protected by the secret professionnel (Article 66-5 of the Law of 31 December 1971). This protection is broader than the common-law attorney-client privilege and applies to written and oral exchanges.

We work on fixed fees for clearly scoped engagements (incorporation, contract drafting, audits) and on monthly retainers for ongoing advisory. Hourly billing is the exception, not the default. You always know the cost before work starts.

Typical timeline is 2–3 weeks from KYC kick-off to RCS registration, assuming standard documentation. Holding-company structures, foreign-shareholder identification or in-kind contributions can extend this — we flag the gating items at the first meeting.

Absolutely. We routinely coordinate with your in-house counsel, expert-comptable or notaire — pragmatic collaboration is the norm, not the exception. We send them everything they need to do their part without duplicating work.

Mariela Petrova

Mariela Petrova

Avocate au Barreau de Paris

Toque #C2396

15+ Years In Corporate Practice

English · French · Russian

Ready When You Are

Talk To A Corporate
Lawyer In France.

A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.

First EngagementFixed Fee

Talk to a French lawyer.

Reply within 24 hours.

Communications protected by professional secrecy — secret professionnel de l'avocat, Article 66-5 of the Law of 31 December 1971.

Continue Reading

Related corporate services in France

01 / Setup

Setting up a French company

Choose between SAS, SARL, SA or SCI — and structure your first French entity around how you actually plan to operate.

Read More
02 / Operating

French commercial contracts

Distribution, agency, supply, services and IP licences — drafted around the protections French law actually gives.

Read More
03 / Disputes

Business disputes & litigation

Shareholder conflicts, commercial breaches and pre-litigation strategy — handled by the same team that knows the file.

Read More